GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapport Therapeutics Inc (NAS:RAPP) » Definitions » Change In Other Working Capital

RAPP (Rapport Therapeutics) Change In Other Working Capital : $-0.72 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Rapport Therapeutics Change In Other Working Capital?

Rapport Therapeutics's Change In Other Working Capital for the quarter that ended in Sep. 2024 was $-0.17 Mil. It means Rapport Therapeutics's Other Working Capital declined by $0.17 Mil from Jun. 2024 to Sep. 2024 .

Rapport Therapeutics's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was $-0.38 Mil. It means Rapport Therapeutics's Other Working Capital declined by $0.38 Mil from Dec. 2022 to Dec. 2023 .

Rapport Therapeutics Change In Other Working Capital Historical Data

The historical data trend for Rapport Therapeutics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapport Therapeutics Change In Other Working Capital Chart

Rapport Therapeutics Annual Data
Trend Dec22 Dec23
Change In Other Working Capital
- -0.38

Rapport Therapeutics Quarterly Data
Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Other Working Capital Get a 7-Day Free Trial 0.04 -0.27 -0.13 -0.14 -0.17

Rapport Therapeutics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.72 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapport Therapeutics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Rapport Therapeutics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapport Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapport Therapeutics Inc (NAS:RAPP) » Definitions » Change In Other Working Capital
Comparable Companies
Traded in Other Exchanges
N/A
Address
1325 Boylston Street, Suite 401, Boston, MA, USA, 02215
Website
https://www.rapportrx.com
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.